Literature DB >> 16129218

Nephrotic syndrome and renal failure after allogeneic stem cell transplantation: novel molecular diagnostic tools for a challenging differential diagnosis.

Paola Romagnani1, Elena Lazzeri, Benedetta Mazzinghi, Laura Lasagni, Stefano Guidi, Alberto Bosi, Calogero Cirami, Maurizio Salvadori.   

Abstract

BACKGROUND: Sudden onset of nephrotic syndrome after allogeneic stem cell transplantation is rare and has been associated mostly with membranous glomerulonephritis related to chronic graft-versus-host disease (cGVHD). We report a case of nephrotic syndrome and rapidly progressive renal failure occurring in a young woman 3 years after allogeneic stem cell transplantation from her HLA-identical brother. In the renal biopsy, a diffuse mononuclear cell infiltrate was observed. Furthermore, histological analysis, immunofluorescence, and electron microscopy of the kidney specimen defined the diagnosis as minimal change disease, a T-cell-mediated glomerulopathy associated with lymphoproliferative disorders, but that has never been described as an isolated manifestation of cGVHD.
METHODS: The differential diagnosis was performed by using immunohistochemistry and laser capture microdissection combined with Taq-Man quantitative polymerase chain reaction.
RESULTS: Infiltrating mononuclear cells in renal tissue consisted of T cells expressing DNA levels of a Y chromosome-specific gene quantitatively similar to those observed in a male subject, showing that these cells derived from the transplant donor and definitely excluding leukemia relapse. However, the large number of infiltrating T cells allowed the possibility that in this patient, minimal change disease could be related to an atypical form of GVHD.
CONCLUSION: This is the first study to use molecular techniques to show the differential diagnosis of nephrotic syndrome after allogeneic stem cell transplantation. This novel method approach might represent a key tool to characterize kidney infiltrate after allogeneic stem cell transplantation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16129218     DOI: 10.1053/j.ajkd.2005.05.026

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  10 in total

1.  A young woman with oedema.

Authors:  Elena Lazzeri; Giuseppe Stefano Netti; Benedetta Mazzinghi; Calogero Cirami; Maurizio Salvadori; Paola Romagnani
Journal:  Intern Emerg Med       Date:  2006       Impact factor: 3.397

2.  Minimal-change nephrotic syndrome in a hematopoietic stem-cell transplant recipient.

Authors:  Benjamin D Humphreys; Vijay K Vanguri; Joel Henderson; Joseph H Antin
Journal:  Nat Clin Pract Nephrol       Date:  2006-09

3.  Nephrotic syndrome in a child after umbilical-cord-blood transplantation.

Authors:  Joo Hoon Lee; Bo Sang Kwon; Il Soo Ha; Hae Il Cheong; Kyung Chul Moon; Hyo Seop Ahn; Yong Choi
Journal:  Pediatr Nephrol       Date:  2006-06-22       Impact factor: 3.714

4.  Treatment with candesartan combined with angiotensin-converting enzyme inhibitor for immunosuppressive treatment-resistant nephrotic syndrome after allogeneic stem cell transplantation.

Authors:  Yuko Osugi; Hiroshi Yamada; Gaku Hosoi; Haruyoshi Noma; Misako Ikemiya; Takefumi Ishii; Masahiro Sako
Journal:  Int J Hematol       Date:  2006-06       Impact factor: 2.490

5.  National Cancer Institute-National Heart, Lung and Blood Institute/pediatric Blood and Marrow Transplant Consortium First International Consensus Conference on late effects after pediatric hematopoietic cell transplantation: long-term organ damage and dysfunction.

Authors:  Michael L Nieder; George B McDonald; Aiko Kida; Sangeeta Hingorani; Saro H Armenian; Kenneth R Cooke; Michael A Pulsipher; K Scott Baker
Journal:  Biol Blood Marrow Transplant       Date:  2011-10-01       Impact factor: 5.742

Review 6.  Toward a Better Understanding of the Atypical Features of Chronic Graft-Versus-Host Disease: A Report from the 2020 National Institutes of Health Consensus Project Task Force.

Authors:  Geoffrey D E Cuvelier; Michelle Schoettler; Nataliya P Buxbaum; Iago Pinal-Fernandez; Marc Schmalzing; Jörg H W Distler; Olaf Penack; Bianca D Santomasso; Robert Zeiser; Klemens Angstwurm; Kelli P A MacDonald; W Taylor Kimberly; Naomi Taylor; Ervina Bilic; Bernhard Banas; Maike Buettner-Herold; Namita Sinha; Hildegard T Greinix; Joseph Pidala; Kirk R Schultz; Kirsten M Williams; Yoshihiro Inamoto; Corey Cutler; Linda M Griffith; Stephanie J Lee; Stefanie Sarantopoulos; Steven Z Pavletic; Daniel Wolff
Journal:  Transplant Cell Ther       Date:  2022-05-31

7.  Renal progenitor cells contribute to hyperplastic lesions of podocytopathies and crescentic glomerulonephritis.

Authors:  Bart Smeets; Maria Lucia Angelotti; Paola Rizzo; Henry Dijkman; Elena Lazzeri; Fieke Mooren; Lara Ballerini; Eliana Parente; Costanza Sagrinati; Benedetta Mazzinghi; Elisa Ronconi; Francesca Becherucci; Ariela Benigni; Eric Steenbergen; Laura Lasagni; Giuseppe Remuzzi; Jack Wetzels; Paola Romagnani
Journal:  J Am Soc Nephrol       Date:  2009-10-29       Impact factor: 10.121

8.  Focal segmental glomerulosclerosis as a complication of graft-versus-host disease.

Authors:  Claudia Fofi; Simona Barberi; Antonella Stoppacciaro; Giorgio Punzo; Paolo Menè
Journal:  Nat Rev Nephrol       Date:  2009-04       Impact factor: 28.314

9.  Minimal change disease in graft versus host disease: a podocyte response to the graft?

Authors:  Janna Huskey; Chris Rivard; Han Myint; Scott Lucia; Maxwell Smith; Michiko Shimada; Takuji Ishimoto; Carlos Araya; Eduardo H Garin; Richard J Johnson
Journal:  Clin Nephrol       Date:  2013-12       Impact factor: 0.975

10.  A case of membranous nephropathy as a manifestation of graft-versus-host disease.

Authors:  Jae Hyun Han; Hyoung Rae Kim; Gi Jeong Kim; Beom Jin Lim; Hyeon Joo Jeong; Hyung Jung Oh; Tae-Hyun Yoo; Shin-Wook Kang; Kyu Hun Choi; Seung Hyeok Han
Journal:  Kidney Res Clin Pract       Date:  2012-10-15
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.